Adverse cardiovascular effects of the coxibs

被引：317
作者：
Dogné, JM
Supuran, CT
Pratico, D
机构：
[1] Univ Liege, Nat & Synth Drugs Res Ctr, B-4000 Cointe Ougree, Belgium
[2] Univ Florence, Chim Bioorgan Lab, Polo Sci, I-50019 Sesto Fiorentino, Italy
[3] Univ Penn, Sch Med, Ctr Expt Therapeut, Dept Pharmacol, Philadelphia, PA 19104 USA
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2005年 / 48卷 / 07期
关键词：
D O I：
10.1021/jm0402059
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：2251 / 2257
页数：7
相关论文
共 26 条
[1]  
Belton O, 2000, CIRCULATION, V102, P840
[2]   Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. [J].
Bombardier, C ;
Laine, L ;
Reicin, A ;
Shapiro, D ;
Burgos-Vargas, R ;
Davis, B ;
Day, R ;
Ferraz, MB ;
Hawkey, CJ ;
Hochberg, MC ;
Kvien, TK ;
Schnitzer, TJ ;
Weaver, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1520-1528
[3]   Selective cyclooxygenase-2 inhibitors: similarities and differences [J].
Brune, K ;
Hinz, B .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2004, 33 (01) :1-6
[4]   COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression [J].
Chandrasekharan, NV ;
Dai, H ;
Roos, KLT ;
Evanson, NK ;
Tomsik, J ;
Elton, TS ;
Simmons, DL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (21) :13926-13931
[5]   Role of prostacyclin in the cardiovascular response to thromboxane A2 [J].
Cheng, Y ;
Austin, SC ;
Rocca, B ;
Koller, BH ;
Coffman, TM ;
Grosser, T ;
Lawson, JA ;
FitzGerald, GA .
SCIENCE, 2002, 296 (5567) :539-541
[6]  
de Leval X, 2004, CURR MED CHEM, V11, P1243
[7]  
DeMaria AN, 2003, J PAIN SYMPTOM MANAG, V25, pS41
[8]   New developments on thromboxane and prostacyclin modulators -: Part I:: Thromboxane modulators [J].
Dogné, JM ;
de Leval, X ;
Hanson, J ;
Frederich, M ;
Lambermont, B ;
Ghuysen, A ;
Casini, A ;
Masereel, B ;
Ruan, KH ;
Pirotte, B ;
Kolh, P .
CURRENT MEDICINAL CHEMISTRY, 2004, 11 (10) :1223-1241
[9]   Recent advances in antiplatelet agents [J].
Dogné, JM ;
de Leval, X ;
Benoit, P ;
Delarge, J ;
Masereel, B ;
David, JL .
CURRENT MEDICINAL CHEMISTRY, 2002, 9 (05) :577-589
[10]   COX-2 and beyond: Approaches to prostaglandin inhibition in human disease [J].
FitzGerald, G .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (11) :879-890
123